Lanean...
Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast
To detect the molecular changes of malignancy in histologically normal breast (HNB) tissues, we recently developed a novel 117-gene-malignancy-signature. Here we report validation of our leading malignancy-risk-genes, topoisomerase-2-alpha (TOP2A), minichromosome-maintenance-protein-2 (MCM2) and “bu...
Gorde:
Egile Nagusiak: | , , , , , , , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
SAGE-Hindawi Access to Research
2011
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3140260/ https://ncbi.nlm.nih.gov/pubmed/21785684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/489064 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|